In Silico Bioequivalence – to replace clinical trial
In silico SD Bioequivalence trial to replace clinical trial
In silico SD Bioequivalence trial to replace clinical trial
Aromatic aldehydes are a class of organic compounds widely used in various industries, including pharmaceuticals, cosmetics, and food additives. However, some of these compounds can exhibit toxicity, posing potential risks to human health and the environment. Quantitative Structure-Toxicity Relationship (QSTR) models offer a valuable tool for predicting the toxicity of chemical compounds based on their molecular structure and properties.
Could in silico predict the toxicity of aromatic aldehydes using Extended Topochemical Atom (ETA) indices as descriptors?
Aromatic aldehydes and their toxicity data was collected and calculated ETA indices from 2D structures. Developed in silico QSTR models using various chemometric tools, such as multiple linear regression (MLR), partial least squares (PLS), or artificial neural networks (ANN), with ETA indices as predictor variables. Validate the developed models using techniques (e.g., leave-one-out cross-validation).
In silico SD Bioequivalence trial to replace clinical trial
In silico clinical trial to support label extension.
Design from Scratch an Influenza Vaccine
Connect with our in silico team of experts to discuss AI solutions and advanced modeling and simulation for the Pharma and Life Science industries and hyper accelerate your success
Our Locations
Copyrights 2024 Ikiminds Pvt Ltd. All Rights Reserved